Mineralys Therapeutics Inc (MLYS)

Stock price, financials, and technical signals for Mineralys Therapeutics Inc (MLYS).

Twitter
Facebook
Email
FinancialsNews & SentimentProCandlestick ProbabilityElite

$13.53

-0.47

(-3.36%)

As of 04/03/2025 5:00 PM ET • Disclaimer
Powered by Stocksift.com

100%

MLYS Performance Snapshot

1-Week Chg

-9.80%

1-Month Chg

51.34%

3-Month Chg

6.12%

6-Month Chg

4.80%

1-Year Chg

4.88%

Year-To-Date Chg

10.45%

Beta 1-Year

1.27

Beta 5-Year

-0.16

Volatility (10-Day)

7.72%

MLYS Technicals

MLYS Financials

Balance Sheet

(USD)

2024 Q4

Y/Y CHANGE

  • Cash and equivalents

    $114.09M

    131.40%

  • Total assets

    $205.90M

    -18.17%

  • Total liabilities

    $14.65M

    39.73%

  • Total investments

    $84.10M

    -55.68%

  • Shareholders' equity

    $191.26M

    -20.69%

  • Book value per share

    $3.83

    -36.28%

Income Statement

(USD)

2024 Q4

Y/Y CHANGE

  • Revenue

    $0

    0%

  • Net income

    -$48.95M

    -100.69%

  • Operating expense

    $51.77M

    86.81%

  • Gross profit

    $0

    0%

  • EBITDA

    -$48.93M

    -100.63%

  • Earnings per share

    -$0.98

    -55.56%

Cash Flow

(USD)

2024 Q4

Y/Y CHANGE

  • Net change in cash

    $16.82M

    145.46%

  • Cash from operations

    -$66.84M

    -130.64%

  • Cash from investing

    $83.57M

    1133.13%

  • Cash from financing

    $90.00K

    21.62%

  • Free cash flow

    -$66.84M

    -130.64%

  • Free cash flow per share

    -$1.34

    -85.32%

Metrics

(USD)

2024 Q4

Y/Y CHANGE

  • Market capitalization

    $612.65M

    73.31%

  • Enterprise value

    $515.38M

    92.88%

  • Shares outstanding

    49.77M

    21.08%

  • Profit margin

    -

    -

  • Gross margin

    -

    -

  • EBITDA margin

    -

    -

Dividends

(USD)

2024 Q4

Y/Y CHANGE

  • Dividend yield

    0%

    0%

  • Dividends per share

    $0

    0%

  • Dividend growth

    -

    -

  • Payout ratio

    0%

    0%

  • Coverage ratio

    -

    -

  • Current ratio

    14.02

    -41.00%

View All Financials